[Commentary] In response to China's latest progress in the development of new coronavirus vaccines, on April 14, Wu Yuanbin, director of the Department of Social Development and Technology of the Ministry of Science and Technology, pointed out at the press conference of the Joint Defense and Joint Control Mechanism of the State Council that three vaccines have been approved Enter clinical trials.
[Same period] Wu Yuanbin, Director of Social Development Department of Ministry of Science and Technology
At present, three vaccines have been approved for clinical trials. Among them, the adenovirus vector vaccine of the academician Chen Wei team was first approved for clinical research. A phase 1 clinical trial (subject vaccination) was completed at the end of March. Recruitment of volunteers for Phase II clinical trials began on April 9, which is the world's first new crown vaccine variety to initiate Phase II clinical research.
[Explanation] When can the new coronavirus vaccine be used? Wu Yuanbin said that the vaccine is a special product for healthy people. Although it is an emergency project in the process of vaccine development, special emphasis must be placed on the scientific and procedural nature.
[Same period] Wu Yuanbin, Director of Social Development Department of Ministry of Science and Technology
At present, the fastest research and development in China, such as adenovirus vector vaccine has started the second phase of clinical trials, but also in the third phase of clinical trials, will be based on the results of clinical trials can be finally determined whether to use, there are some procedures for approval.
[Explanation] During the fight against new coronary pneumonia, a number of effective Chinese patent medicines and classic prescriptions have appeared. Li Yu, director of the Science and Technology Department of the State Administration of Traditional Chinese Medicine, said at the meeting that during the fight against the epidemic, TCM has screened out effective prescriptions of "three medicines and three prescriptions" through clinical trials and played an important role.
[Same period] Li Yu, Director of Science and Technology Department of State Administration of Traditional Chinese Medicine
The "three medicines" are Jinhua Qinggan Granules, Lianhua Qingwen Granules and capsules and Xuebijing Injection. These three medicines are all old drugs that have been approved in the market and have been used in the treatment of new coronary pneumonia The important role shows good clinical efficacy.
[Explanation] Li Yu introduced that in view of the important role played by the "three drugs and three prescriptions", especially the "three drugs" in the epidemic and the good clinical evidence obtained, the State Food and Drug Administration has approved the treatment of new coronary pneumonia into the "three drugs" New drug indications.
Reporter Xu Pengpeng reports from Beijing
Editor in charge: [Lu Yan]